DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on Thursday, May 12, 2022. The company will host a conference call and webcast at 8:30 am Eastern Time.